Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.035M |
Day Range | - - - |
52 Wk Range | 25.980 - 110.250 |
Market Cap | $6.839B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 20.7% |
Days to Cover | 6.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cytokinetics (NASDAQ: CYTK) through any online brokerage.
Other companies in Cytokinetics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Cytokinetics (NASDAQ: CYTK) was reported by Needham on Tuesday, April 9, 2024. The analyst firm set a price target for 108.00 expecting CYTK to rise to within 12 months (a possible 65.14% upside). 34 analyst firms have reported ratings in the last year.
The stock price for Cytokinetics (NASDAQ: CYTK) is $65.4001 last updated April 25, 2024 at 5:55 PM EDT.
There are no upcoming dividends for Cytokinetics.
Cytokinetics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Cytokinetics.
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.